(Q39510505)

12 September 2017

1 reference

title

Epstein-Barr virus-associated malignancies (English)

1 reference

12 September 2017

0 references

Richtsmeier WJ

1

1 reference

12 September 2017

Wittels EG

series ordinal

2

1 reference

12 September 2017

Mazur EM

series ordinal

3

1 reference

12 September 2017

publication date

1 January 1987

1 reference

Critical Reviews in Clinical Laboratory Sciences

12 September 2017

published in

1 reference

12 September 2017

volume

25

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

105-136

1 reference

Evolution of infectious mononucleosis into Epstein-Barr virus carrying monoclonal malignant lymphoma

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: Correlated nucleic acid hybridization and histopathological examination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

The Epstein-Barr virus and EB virus infections in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Carcinoma of the nasopharynx in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Primary epstein-barr virus infections in African infants. II. Clinical and serological observations during seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Burkitt lymphoma in Papua, New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Fatal Lymphoma after Transplantation of Cultured Thymus in Children with Combined Immunodeficiency Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

A cluster of young patients with Burkitt's lymphoma and nasopharyngeal carcinoma in central Texas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Immunoregulation during acute infection with Epstein-Barr virus: dynamics of interferon and 2',5'-oligoadenylate synthetase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Association of some supraglottic laryngeal carcinomas with EB virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

A sarcoma involving the jaws in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Lack of regression in Epstein-Barr virus infected leucocyte cultures of nasopharyngeal carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Replication of Epstein-Barr virus DNA in lymphoblastoid cells treated for extended periods with acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Characterisation of Epstein-Barr virus-specific memory T cells from the peripheral blood of seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Is Burkitt's lymphoma related to perinatal infection by Epstein-Barr virus?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Transcriptional activation of the translocated c-myc oncogene in burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: Comparison of serum antibody titre, cellular antigen content and histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Persistent Epstein-Barr virus infection and pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

The Significance of Serologic Test for EB-Virus Antibody in Occult Type Nasopharyngeal Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Occurrence of malignancy in immunodeficiency diseases. A literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Human Nasopharyngeal Carcinomas Positive for Epstein-Barr Virus DNA in North America2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Burkitt lymphoma in a patient with classic hemophilia receiving factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Chronic active Epstein-Barr virus infections in two immunodeficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Natural killer cells: characteristics and regulation of activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Central-nervous-system lymphoma related to Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Risk of cancer in renal-transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-barr virus (EBV)-induced lymphoproliferative disease in cotton-topped marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Latent Herpesviruses of Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

The Biology and Chemistry of Epstein-Barr Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

The Epstein-Barr Virus and Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Malignant Neoplasms Following Cardiac Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Association of Epstein-Barr virus with nasopharyngeal carcinoma in Alaskan native patients: serum antibodies and tissue EBNA and DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-Barr virus-specific antibody titers in seven Alaskan Natives before and after diagnosis of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Complement-fixing antibody to epstein-barr virus soluble antigen in populations at high and low risk for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Association of Epstein-Barr virus with thymic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-Barr Virus: Inhibition of Replication by Three New Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Antibodies to Epstein–Barr-Virus Antigens before and after the Development of Burkitt's Lymphoma in a Patient Treated for Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Prognostic factors in Burkitt's lymphoma importance of total tumor burden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Marker band in one chromosome 14 from Burkitt lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Angioimmunoblastic lymphadenopathy evolution to a Burkitt-like lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Somatic rearrangement of chromosome 14 in human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Chromosome 14 translocation in African and North American Burkitt's lymphoma;

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Early primary infection and high Epstein-Barr virus antibody titers in Greenland Eskimos at high risk for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein–Barr Virus — Immortalization and Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Site of Epstein-Barr virus replication in the oropharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Intervening effect of L-ascorbic acid on Epstein-Barr virus activation in human lymphoblastoid cells and its comparison with the effect of retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Nasopharyngeal cancer--a historical vignette

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Cyclosporin A immunosuppression, Epstein-Barr antibody, and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Antibodies to Epstein-Barr Virus in Patients with Nasopharyngeal Carcinoma and in Comparison Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Application of Epstein‐Barr Virus Serology to the Diagnosis and Staging of North American Patients with Nasopharyngeal Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Tumorigenicity of human hematopoietic cell lines in athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Interferon—Present and Future Prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Virology: Epstein–Barr virus in epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-barr virus-specific serodiagnostic tests in carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein–Barr Virus — Oncogen or Mitogen?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Cofactors in disease: Epstein-Barr virus, oncogenes, and Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-Barr-virus induced lymphoproliferation. Implications for antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Serological testing for Epstein-Barr virus--developments in interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Infectious Mononucleosis in an Adult Progressing to Fatal lmmunoblastic Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Improved Test for IgM Antibody to Epstein-Barr Virus Using an Absorption Step with Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Infection of human epithelial cell lines by Epstein-Barr virus. Interaction between epithelial cell and B lymphocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-Barr virus activation of human epithelial-nasopharyngeal carcinoma hybrid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Titers of Epstein-Barr Virus-related antibodies in nasopharyngeal carcinoma in japan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Antibody responses to epstein-barr virus-specific DNase in relation to the prognosis of juvenile patients with nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

A culture method giving substantial yields of normal nasopharyngeal epithelial cells for work with Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Development and persistence of immunity to Epstein-Barr virus in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-barr virus antibodies in tonsillar carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-Barr virus and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Unique cell lines harbouring both Epstein-Barr virus and adult T-cell leukaemia virus, established from leukaemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Detection of epstein-barr virus IgA/EA antibody for diagnosis of nasopharyngeal carcinoma by immunoautoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein-Barr virus activation in Raji cells with ether extracts of soil from different areas in China

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105879

10.3109/10408368709105879

21 January 2018

Identifiers

DOI

0 references

1 reference